211 related articles for article (PubMed ID: 33316141)
1. A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function.
Bencivenga D; Stampone E; Aulitto A; Tramontano A; Barone C; Negri A; Roberti D; Perrotta S; Della Ragione F; Borriello A
Mol Oncol; 2021 Apr; 15(4):915-941. PubMed ID: 33316141
[TBL] [Abstract][Full Text] [Related]
2. p27
Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A
Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control.
Jäkel H; Weinl C; Hengst L
Oncogene; 2011 Aug; 30(32):3502-12. PubMed ID: 21423214
[TBL] [Abstract][Full Text] [Related]
4. Post-translational regulation of the tumor suppressor p27(KIP1).
Vervoorts J; Lüscher B
Cell Mol Life Sci; 2008 Oct; 65(20):3255-64. PubMed ID: 18636226
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype.
Occhi G; Regazzo D; Trivellin G; Boaretto F; Ciato D; Bobisse S; Ferasin S; Cetani F; Pardi E; Korbonits M; Pellegata NS; Sidarovich V; Quattrone A; Opocher G; Mantero F; Scaroni C
PLoS Genet; 2013 Mar; 9(3):e1003350. PubMed ID: 23555276
[TBL] [Abstract][Full Text] [Related]
6. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
7. The function of p27 KIP1 during tumor development.
Lee J; Kim SS
Exp Mol Med; 2009 Nov; 41(11):765-71. PubMed ID: 19887899
[TBL] [Abstract][Full Text] [Related]
8. Loss of p27
Berton S; Cusan M; Segatto I; Citron F; D'Andrea S; Benevol S; Avanzo M; Dall'Acqua A; Schiappacassi M; Bristow RG; Belletti B; Baldassarre G
Sci Rep; 2017 Apr; 7(1):595. PubMed ID: 28377607
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.
Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M
Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303
[TBL] [Abstract][Full Text] [Related]
11. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
12. Transfection of p27(Kip1) threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells.
Kudo Y; Kitajima S; Sato S; Ogawa I; Miyauchi M; Takata T
Oncology; 2002; 63(4):398-404. PubMed ID: 12417796
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.
Lovisa S; Citro S; Sonego M; Dall'Acqua A; Ranzuglia V; Berton S; Colombatti A; Belletti B; Chiocca S; Schiappacassi M; Baldassarre G
J Mol Cell Biol; 2016 Feb; 8(1):17-30. PubMed ID: 26450989
[TBL] [Abstract][Full Text] [Related]
14. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
Zhang W; Bergamaschi D; Jin B; Lu X
Blood; 2005 May; 105(9):3691-8. PubMed ID: 15665120
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
Zhu L; Chiao CY; Enzer KG; Stankiewicz AJ; Faller DV; Dai Y
Mol Cancer Res; 2015 Jan; 13(1):41-9. PubMed ID: 25143434
[TBL] [Abstract][Full Text] [Related]
17. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
[TBL] [Abstract][Full Text] [Related]
18. Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.
Lu M; Fei M; Cheng C; Wang Y; He S; Zhao Y; Gao S; Ke Q; Li P; Cui X; Shen A
Arch Med Res; 2008 Aug; 39(6):573-81. PubMed ID: 18662588
[TBL] [Abstract][Full Text] [Related]
19. Mutations of phosphorylation sites Ser10 and Thr187 of p27Kip1 abolish cytoplasmic redistribution but do not abrogate G0/1 phase arrest in the HepG2 cell line.
Guan X; Chen L; Wang J; Geng H; Chu X; Zhang Q; Du L; De W
Biochem Biophys Res Commun; 2006 Sep; 347(3):601-7. PubMed ID: 16842750
[TBL] [Abstract][Full Text] [Related]
20. Down-Regulation of CK2α Leads toUp-Regulation of the Cyclin-Dependent Kinase Inhibitor p27
Guerra B; Dembic M; Siddiqui MA; Dominguez I; Ceppi P; Andresen BS
Cell Physiol Biochem; 2020 Nov; 54(6):1177-1198. PubMed ID: 33216476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
